|
|
|
|
|
|
|
|
|
|
|
|
 |
Algen Biopharmaceuticals Inc.
|
 |
|
Algen is a US-based company, established by Yissum, the R&D company of the Hebrew University of Jerusalem. Developing a technique for tricking cancer cells into “committing suicide” and thus preventing their spread. |
|
Read More... |
|
ANGIOB LTD.
|
|
AngioB develops proprietary novel pro-angiogenic drugs to treat cardiovascular diseases and peripheral ischemic disorders. The Company presents a novel strategy for therapeutic angiogenesis, which differs from the current approaches in the basic structure of the developed agent and in its angiogenic target protein. |
|
Read More... |
|
Atox Bio Inc.
|
 |
|
Atox Bio is focused on the discovery and development of therapeutics for the treatment of infectious and autoimmune diseases mediated by excessive T-cell response. Having developed novel immunomodulators that reduce autoimmune response, as well as novel antagonists that block the action of a family of deadly bacterial toxins termed super antigens, Atox Bio is developing products for treatment of: Infectious diseases - toxic shock (including a biodefense countermeasure against super antigen toxins) and Gram-positive septic shock, both of which are lethal and constitute a strong unmet medical need; Autoimmune diseases - including rheumatoid arthritis, multiple sclerosis and psoriasis. |
|
Read More... |
|
BioCancell Therapeutics Ltd. (formerly DBT Biopharmaceuticals)
|
 |
|
BioCancell is specializing in the development of patient-oriented, targeted therapy for the treatment of a wide range of cancers. Its therapeutic and diagnostic technology constitutes a novel 'search and destroy' paradigm for the targeted destruction of cancer cells - with no effect on surrounding tissue and no observed side effects - for long-term, safe treatment and prevention of cancer. |
|
Read More... |
|
Biosensor Application AB
|
 |
|
Biosensor Application AB is a public Swedish company located in Solna, a suburb north of Stockholm. It is listed at the Aktietorget stock exchange in Stockholm. The company develops, manufactures and sells biotechnology based vapor and trace detection systems.
|
|
Read More... |
|
BonTom Vegetable Breeding and Research Group
|
 |
|
The BonTom Tomato Breeding Group is based in Rehovot, Israel, at the Faculty of Agriculture - one of the Hebrew University of Jerusalem’s seven faculties. Operating as part of the Faculty’s Robert H. Smith Institute of Plant Sciences and Genetics in Agriculture, BonTom is recognized as one of the largest and leading tomato breeding groups worldwide. Under the leadership of Professors Nachum Kedar and Haim Rabinowitch, BonTom has bred and released numerous tomato varieties, providing farmers and customers with better solutions for their growing and marketing needs. |
|
Read More... |
|
BriefCam Ltd.
|
 |
|
BriefCam is an early stage start-up company, established to develop and
commercialize video synopsis, summarization and indexing technology.
The initial technology of video synopsis was developed at The Hebrew
University of Jerusalem, and is licensed by BriefCam. |
|
Read More... |
|
CBD Technologies Ltd.
|
 |
|
CBD Technology develops a broad application generating platform based on Cellulose Binding Domain (CBD) Technology. Protein-engineering focus areas for product, process and application development include bioseparation (antibody purification, sample capture for rare analyte diagnostics and analysis), bioprocessing (single-step enzyme purification and immobilization for the production of pharma intermediates, bioremediation). Gene-driven applications are focussed on the modulation of plant growth by intervention in cellulose biosynthesis. Growth modulation is focussed on increased biomass (forestry, forage crops), altered digestibility and carbohydrate properties in plants. |
|
Chiasma Inc.
|
 |
|
Chiasma develops solutions for delivering protein-based drugs in a non-invasive manner. The company technology is designed to enable drugs to reach the bloodstream without an injection. Proteins taken orally usually dissolve while still in the intestine, without entering the bloodstream. |
|
Read More... |
|
CollPlant Ltd.
|
 |
|
CollPlant is developing a production system in transgenic tobacco to manufacture human recombinant collagen I with improved thermal stability. |
|
Read More... |
|
CoolSite
|
 |
|
CoolCite is an innovative global portal for scholars and scholarship. It started with a basic insight, namely that each scholar manages his or her individual CV, but the data in those text files is mostly lost because they are disconnected from other CVs and from a common database. Consequently, current "global" databases of scholarship are limited because they use partial information from publishers and institutions rather than directly from scholars. Consequently, a lot of information on academic activities and products is lost, and available data is biased toward some countries and languages. |
|
Read More... |
|
ConjuGate Ltd.
|
 |
|
ConjuGate is developing a novel antifungal therapy for systemic treatment, which will be used for the treatment of acute invasive fungal infections in patients with compromised immune system. The product is based on the company's unique and patent protected technology which enables to improve the properties of existing drugs. The antifungal treatment will be significantly less toxic and more cost-effective than existing treatments. |
|
Read More... |
|
ELUTEX LTD.
|
|
ELUTEX LTD. is a development stage company dedicated to bringing
therapeutic combinations to medical devices in order to improve
performance and patient well being.
ELUTEX's patented and proprietary electro-polymerization process
is utilized in coating implantable, metallic medical devices. The
company is positioned to capitalize on the growing trend toward
drug/device combination products and seeks to offer biocompatible
and drug-eluting nano-coatings unto metallic medical devices such
as cardiovascular stents and orthopedic implants.
|
|
Read More... |
|
En Gibton Ltd.
|
 |
|
EN GIBTON is a scientific Start-up Company, Which develops innovative water treatment filtration-adsorption technology products. It is supported by Ashkelon Technological Incubator and the Israeli government's Chief Scientist Office. |
|
Read More... |
|
Ester Neurosciences Ltd.
|
 |
|
Ester Neurosciences is a clinical stage biopharmaceutical company developing novel therapeutic products for treatment of neurological and neuromuscular disorders. Ester’s lead product Monarsen(TM) has already demonstrated safety and efficacy in phase Ib and phase IIa clinical trials for the treatment of Myasthenia Gravis (MG). The orally available product looks to have superior efficacy, longer duration of action and a more favorable side effect profile than the current standard of care for MG. Monarsen(TM) is also in advanced preclinical development for treatment of Amyotrophic Lateral Sclerosis (ALS). In parallel, the company is developing small molecule therapeutics to treat mass-market CNS disorders including Alzheimer’s disease (AD) and Traumatic Brain Injury (TBI). |
|
Read More... |
|
Ex Libris Ltd.
|
 |
|
Ex Libris is a leading developer and provider of high-performance applications for libraries, information centers, and researchers. The company's products include ALEPH, an integrated library solution; MetaLib(R), an information portal for library collections; SFX(R), a context-sensitive linking solution for heterogeneous electronic resources in the scholarly information environment; DigiTool(R), a solution for the construction of digital collections; Verde(R), an electronic resource management (ERM) system; and Primo(R), a next-generation, user-centric discovery and delivery solution. |
|
Read More... |
|
Gene Vector Technologies (GVT) Ltd.
|
 |
|
Gene Vector Technologies (GVT) establishes itself as a leader in the field of gene therapy by capitalizing on the numerous clinical applications offered by its proprietary technology. GVT is currently focusing on developing gene therapies for liver-related diseases. The first development is for the treatment of Hemophilia A patients by delivering the Human Factor VIII gene to the liver. |
|
HumanEyes Technologies Ltd.
|
 |
|
HumanEyes introduces software products that enable the simple creation of panoramic 3D stereo images from ordinary photographs captured by any single still or video digital camera. |
|
Read More... |
|
Intec Pharma Ltd.
|
 |
|
Intec developed an effective gastro-retentive technology platform, designed for drugs with a narrow window of absorption in the stomach and duodenum. |
|
Read More... |
|
|
|
|
|
|
 |
|
|
